Skip to main content
TipRanks
Go Ultimate75% OFF

William Denby Insider Profile

4 Followers

William Denby, former Director at DMK Pharmaceuticals, holds 108.75K shares in DMK Pharmaceuticals (Ticker: DMKPQ), holds 0.00 shares in Santarus (Ticker: SNTS). Most recently, William Denby Bought ― shares of DMK Pharmaceuticals on May 28, 2019 for an estimated value of $9.94K.

William Denby's Trading History

DMKPQ
DMK Pharmaceuticals
May 28, 2019―Informative Buy9.94K―
SNTS
Santarus
Jan 06, 2014―Uninformative Sell6.47M―

You May Also Like

William Denby insider profile FAQ

What is the percentage of profitable transactions made by William Denby?
The percentage of profitable transactions made by William Denby is 0%.
What is the average return per transaction made by William Denby?
The average return per transaction made by William Denby is -46.40%.
What stocks does William Denby hold?
William Denby holds: DMKPQ, SNTS stocks.
What was William Denby’s latest transaction?
William Denby’s latest transaction was an Informative Buy of $9.94K.
What was William Denby's most profitable transaction?
William Denby’s most profitable transaction was an Informative Buy of DMKPQ stock on September 3, 2014. The return on the trade was -25.80%.
What is William Denby's role in DMK Pharmaceuticals?
William Denby's role in DMK Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.